Example: Heart Attack

Search clinical trials for: Poly I-C

Total 49 results

NCT01437605

Terminated

Phase II Study to Assess the Safety and Immunogenicity of recMAGE-A3+AS15 ASCI With or Without Poly IC:LC

Conditions: Melanoma
NCT02532413

Unknown status

Antiviral Efficacy of the Combination Treatment With Poly IC and Entecavir for Chronic Hepatitis B

Conditions: Chronic Hepatitis B
NCT00694551

Completed

PSMA and TARP Peptide Vaccine With Poly IC-LC Adjuvant in HLA-A2 (+) Patients With Elevated PSA After Initial Definitive Treatment

Conditions: Prostate Cancer
NCT01008527

Completed

Phase I Oncovir Poly IC:LC and NY-ESO-1/gp100

Conditions: Melanoma
NCT00035893

Completed

The Role of Ampligen in Strategic Therapeutic Intervention (STI) of HAART

Conditions: HIV Seropositivity; HIV Infection
NCT03732547

Recruiting

Study of PolyIC and PD-1 mAb in Subjects With Unresectable Hepatocellular Carcinoma

Conditions: Carcinoma, Hepatocellular
NCT00035581

Terminated

Safety and Efficacy of Ampligen in the Treatment of HIV Patients Failing HAART

Conditions: HIV Seropositivity; HIV Infection
NCT03131765

Unknown status

Dose Escalation and Cohort Expansion Study of YS-ON-001 in Patients With Advanced Solid Tumors

Conditions: Cancer
NCT03198676

Completed

A Safety Study to Compare the Effect of Two PrEP-001 Nasal Powder Formulations on Nasal Mucosa and Serum Cytokine Production

Conditions: Upper Respiratory Tract Infections
NCT02090374

Completed

Development of Human Nasal Challenge Models With Microbial Constituents and Grass Pollen

Conditions: Allergic Rhinitis; Asthma; Latent Tuberculosis
NCT03262103

Recruiting

Neoadjuvant Hiltonol® (PolyICLC) for Prostate Cancer

Conditions: Prostate Cancer
NCT02078648

Completed

Safety and Efficacy Study of SL-701, a Glioma-Associated Antigen Vaccine To Treat Recurrent Glioblastoma Multiforme

Conditions: Adult Brain Glioblastoma; Glioblastoma Multiforme
NCT03338556

Completed

A Study to Examine the Duration of Effect of PrEP-001 in Healthy Subjects Challenged With HRV-16

Conditions: Viral Upper Respiratory Tract Infection
NCT02834052

Recruiting

Pembrolizumab + Poly-ICLC in MRP Colon Cancer

Conditions: Metastatic Colon Cancer; Solid Tumor
NCT00094003

Completed

Study of NS-9 in Patients With Liver Metastases

Conditions: Liver Neoplasms; Neoplasm Metastasis; Local Neoplasm Recurrences
NCT03956056

Recruiting

Neoantigen Peptide Vaccine Strategy in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy

Conditions: Pancreas Cancer; Pancreatic Cancer; Cancer of the Pancreas
NCT01079741

Completed

Safety Study of Adjuvant Vaccine to Treat Melanoma Patients

Conditions: Melanoma
NCT01591473

Terminated

Safety Study of FluMist With and Without Ampligen

Conditions: Influenza, Human
NCT00215813

Available

Ampligen in Chronic Fatigue Syndrome

Conditions: Chronic Fatigue Syndrome
NCT01299662

Completed

Polyinosinic-Polycytidylic Acid-poly-L-lysine Carboxymethylcellulose (Poly-ICLC) in Healthy Volunteers

Conditions: Healthy Volunteers
NCT02166905

Active, not recruiting

DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, and IDO1 Inhibitor INCB024360 in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission

Conditions: Fallopian Tube Carcinoma; Ovarian Carcinoma; Primary Peritoneal Carcinoma
NCT00986609

Completed

MUC1 Vaccine for Triple-negative Breast Cancer

Conditions: Breast Cancer; Inflammatory Breast Cancer; Stage I Breast Cancer; Stage II Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer; Triple-negative Breast Cancer
NCT01842139

Completed

Vaccine Therapy and Basiliximab in Treating Patients With Acute Myeloid Leukemia in Complete Remission

Conditions: Adult Acute Myeloid Leukemia in Remission; Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(15;17)(q22;q12); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)
NCT01720836

Recruiting

Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Conditions: Non-small Cell Lung Cancer (NSCLC)
NCT00374049

Completed

MUC1 Vaccine in Conjunction With Poly-ICLC in Patients With Recurrent and/or Advanced Prostate Cancer

Conditions: Prostate Cancer